QSAM Biosciences Balance Sheet Health
Financial Health criteria checks 4/6
QSAM Biosciences has a total shareholder equity of $672.3K and total debt of $7.5K, which brings its debt-to-equity ratio to 1.1%. Its total assets and total liabilities are $1.7M and $1.0M respectively.
Key information
1.1%
Debt to equity ratio
US$7.50k
Debt
| Interest coverage ratio | n/a |
| Cash | US$1.39m |
| Equity | US$672.35k |
| Total liabilities | US$1.03m |
| Total assets | US$1.71m |
Recent financial health updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 2Q20's short term assets ($1.7M) exceed its short term liabilities ($1.0M).
Long Term Liabilities: 2Q20 has no long term liabilities.
Debt to Equity History and Analysis
Debt Level: 2Q20 has more cash than its total debt.
Reducing Debt: 2Q20 had negative shareholder equity 5 years ago, but is now positive and has therefore improved.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 2Q20 has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: 2Q20 has less than a year of cash runway if free cash flow continues to reduce at historical rates of 20.9% each year